Literature DB >> 33554224

Head and neck cancer exosomes drive microRNA-mediated reprogramming of local neurons.

Patrick J Hunt1,2, Moran Amit3.   

Abstract

Solid tumors are complex collections of cells surrounded by benign tissues that influence and are influenced by the tumor. These surrounding cells include vasculature, immune cells, neurons, and other cell types, and are collectively known as the tumor microenvironment. Tumors manipulate their microenvironment for the benefit of the tumor. Autonomic neurons innervate and drive malignant growth in a variety of solid tumors. However, the mechanisms underlying neuron-tumor relationships are not well understood. Recently, Amit et al. described that trophic relationships between oral cavity squamous cell carcinomas (OCSCCs) and nearby autonomic neurons arise through direct signaling between tumors and local neurons. An inducible tumor model in which 4NQO was introduced into the drinking water of Trp53 knockout mice was used to model OCSCC-microenvironment interactions. Using this model, this group discovered that loss of p53 expression in OCSCC tumors resulted in increased nerve density within these tumors. This neuritogenesis was controlled by tumor-derived microRNA-laden extracellular vesicles (EVs). Specifically, EV-delivered miR-34a inhibited neuritogenesis, whereas EV-delivered miR-21 and miR-324 increased neuritogenesis. The neurons innervating p53-deficient OCSCC tumors were predominantly adrenergic and arose through the transdifferentiation of trigeminal sensory nerve fibers to adrenergic nerve fibers. This transdifferentiation corresponded with increased expression of neuron-reprogramming transcription factors, including POU5F1, KLF4, and ASCL1, which were overexpressed in the p53-deficient samples, and are proposed targets of miR-34a-mediated regulation. Human OCSCC samples enriched in adrenergic neuron markers are associated strongly with poor outcomes, thus demonstrating the relevance of these findings to cancer patients.

Entities:  

Keywords:  MicroRNA; adrenergic neurons; microenvironment; neuron-tumor crosstalk; neurotrophic growth; solid tumors

Year:  2020        PMID: 33554224      PMCID: PMC7861575          DOI: 10.20517/evcna.2020.04

Source DB:  PubMed          Journal:  Extracell Vesicles Circ Nucl Acids


  30 in total

1.  In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer.

Authors:  G E Ayala; T M Wheeler; H D Shine; M Schmelz; A Frolov; S Chakraborty; D Rowley
Journal:  Prostate       Date:  2001-11-01       Impact factor: 4.104

Review 2.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

Review 3.  Microenvironment of liver regeneration in liver cancer.

Authors:  Han-Min Li; Zhi-Hua Ye
Journal:  Chin J Integr Med       Date:  2017-05-18       Impact factor: 1.978

Review 4.  β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.

Authors:  W Kurtis Childers; Christopher S Hollenbeak; Pramil Cheriyath
Journal:  Clin Breast Cancer       Date:  2015-07-10       Impact factor: 3.225

Review 5.  Tumor microenvironment: recent advances in various cancer treatments.

Authors:  J-J Wang; K-F Lei; F Han
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-06       Impact factor: 3.507

Review 6.  Neural plasticity in pancreatitis and pancreatic cancer.

Authors:  Ihsan Ekin Demir; Helmut Friess; Güralp O Ceyhan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

7.  Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.

Authors:  Helene Hartvedt Grytli; Morten Wang Fagerland; Sophie D Fosså; Kristin Austlid Taskén
Journal:  Eur Urol       Date:  2013-01-14       Impact factor: 20.096

8.  Electrical and synaptic integration of glioma into neural circuits.

Authors:  Humsa S Venkatesh; Wade Morishita; Anna C Geraghty; Dana Silverbush; Shawn M Gillespie; Marlene Arzt; Lydia T Tam; Cedric Espenel; Anitha Ponnuswami; Lijun Ni; Pamelyn J Woo; Kathryn R Taylor; Amit Agarwal; Aviv Regev; David Brang; Hannes Vogel; Shawn Hervey-Jumper; Dwight E Bergles; Mario L Suvà; Robert C Malenka; Michelle Monje
Journal:  Nature       Date:  2019-09-18       Impact factor: 49.962

9.  Loss of p53 drives neuron reprogramming in head and neck cancer.

Authors:  Moran Amit; Hideaki Takahashi; Mihnea Paul Dragomir; Antje Lindemann; Frederico O Gleber-Netto; Curtis R Pickering; Simone Anfossi; Abdullah A Osman; Yu Cai; Rong Wang; Erik Knutsen; Masayoshi Shimizu; Cristina Ivan; Xiayu Rao; Jing Wang; Deborah A Silverman; Samantha Tam; Mei Zhao; Carlos Caulin; Assaf Zinger; Ennio Tasciotti; Patrick M Dougherty; Adel El-Naggar; George A Calin; Jeffrey N Myers
Journal:  Nature       Date:  2020-02-12       Impact factor: 69.504

Review 10.  Extracellular Vesicles Arising from Apoptotic Cells in Tumors: Roles in Cancer Pathogenesis and Potential Clinical Applications.

Authors:  Catherine Lynch; Maria Panagopoulou; Christopher D Gregory
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

View more
  3 in total

Review 1.  The Role of Extracellular Vesicles in Cancer-Nerve Crosstalk of the Peripheral Nervous System.

Authors:  Yuanning Guo; Ziv Gil
Journal:  Cells       Date:  2022-04-11       Impact factor: 7.666

Review 2.  Understanding the tumor microenvironment in head and neck squamous cell carcinoma.

Authors:  Habib Sadeghi Rad; Yavar Shiravand; Payar Radfar; Rahul Ladwa; Chris Perry; Xiaoyuan Han; Majid Ebrahimi Warkiani; Mark N Adams; Brett Gm Hughes; Ken O'Byrne; Arutha Kulasinghe
Journal:  Clin Transl Immunology       Date:  2022-06-06

Review 3.  Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche.

Authors:  Jiayan Shi; Jia Xu; Yang Li; Bowen Li; Hui Ming; Edouard C Nice; Canhua Huang; Qifu Li; Chuang Wang
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.